Screener
Assembly Biosciences ASMB Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Assembly Biosciences in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Assembly Biosciences’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211987
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Marketable securities | 195,481 | 189,656 |
| Accounts receivable from collaboration with a related party | 451 | 974 |
| Prepaid expenses and other current assets | 5,561 | 5,469 |
| Total current assets | 232,613 | 254,549 |
| Property and equipment, net | 214 | 221 |
| Operating lease right-of-use (ROU) assets | 2,369 | 2,508 |
| Other assets | 312 | 312 |
| Total assets | $235,508 | $257,590 |
Item 1. Financial Statements
FAQ
- What is Assembly Biosciences's total current assets?
- Assembly Biosciences (ASMB) reported total current assets of $232.61M in Q1 2026.
- How has Assembly Biosciences's total current assets changed year-over-year?
- Assembly Biosciences's total current assets increased by 143.5% year-over-year, from $95.53M to $232.61M.
- What is the long-term trend for Assembly Biosciences's total current assets?
- Over 5 years (2020 to 2025), Assembly Biosciences's total current assets has grown at a 2.5% compound annual growth rate (CAGR), from $224.49M to $254.55M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Assembly Biosciences's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude